THEORETICAL CONSIDERATIONS IN THE CALCULATION OF BIOAVAILABILITY OF DRUGS EXHIBITING MICHAELIS-MENTEN ELIMINATION KINETICS

被引：25

作者：

RUBIN, GM ^{[1
]}

TOZER, TN ^{[1
]}

机构：

[1] UNIV CALIF SAN FRANCISCO,DEPT PHARM,SAN FRANCISCO,CA 94143

来源：

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1984年 / 12卷 / 04期

关键词：

D O I：

10.1007/BF01062667

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：437 / 450

页数：14

共 14 条

[1] MODELS OF HEPATIC DRUG CLEARANCE - DISCRIMINATION BETWEEN THE WELL STIRRED AND PARALLEL-TUBE MODELS [J].

AHMAD, AB ;

BENNETT, PN ;

ROWLAND, M .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1983, 35 (04) :219-224

[2] NONLINEAR ASSESSMENT OF PHENYTOIN BIOAVAILABILITY [J].

JUSKO, WJ ;

KOUP, JR ;

ALVAN, G .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (04) :327-336

[3]

KEIDING S, 1978, J PHARMACOL EXP THER, V205, P465

[4] 1ST-PASS EFFECT - NON-LINEAR CONCEPT COMPRISING AN EXPLICIT SOLUTION OF INTEGRATED MICHAELIS-MENTEN EQUATION [J].

KELLER, F ;

SCHOLLE, J .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (02) :195-198

[5] BIOAVAILABILITY CALCULATIONS FOR DRUGS SHOWING SIMULTANEOUS FIRST-ORDER AND CAPACITY-LIMITED ELIMINATION KINETICS [J].

MARTIS, L ;

LEVY, RH .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (04) :283-294

[6]

MCLEAN AJ, 1978, CLIN PHARMACOL THER, V24, P5

[7] EFFECT OF ALTERED PLASMA-PROTEIN BINDING ON APPARENT VOLUME OF DISTRIBUTION [J].

OIE, S ;

TOZER, TN .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (09) :1203-1205

[8]

Pang K S, 1977, J Pharmacokinet Biopharm, V5, P625, DOI 10.1007/BF01059688

[9]

Pang K S, 1977, J Pharmacokinet Biopharm, V5, P655, DOI 10.1007/BF01059689

[10]

RIEGELMAN S, 1973, J PHARMACOKIN BIOPHA, V1, P418

← 1 2 →